Literature DB >> 24522923

Differential properties of cytomegalovirus pUL97 kinase isoforms affect viral replication and maribavir susceptibility.

Rike Webel1, Morgan Hakki, Mark N Prichard, William D Rawlinson, Manfred Marschall, Sunwen Chou.   

Abstract

UNLABELLED: The human cytomegalovirus (HCMV)-encoded kinase pUL97 is required for efficient viral replication. Previous studies described two isoforms of pUL97, the full-length isoform (M1) and a smaller isoform likely resulting from translation initiation at codon 74 (M74). Here, we report the detection of a third pUL97 isoform during viral infection resulting from translation initiation at codon 157 (isoform M157). The consistent expression of isoform M157 as a minor component of pUL97 during infection with clinical and laboratory-adapted HCMV strains was suppressed when codon 157 was mutagenized. Viral mutants expressing specific isoforms were generated to compare their growth and drug susceptibility phenotypes, as well as pUL97 intracellular localization patterns and kinase activities. The exclusive expression of isoform M157 resulted in substantially reduced viral growth and resistance to the pUL97 inhibitor maribavir while retaining susceptibility to ganciclovir. Confocal imaging demonstrated reduced nuclear import of amino-terminal deletion isoforms compared to isoform M1. Isoform M157 showed reduced efficiency of various substrate protein interactions and autophosphorylation, whereas Rb phosphorylation was preserved. These results reveal differential properties of pUL97 isoforms that affect viral replication, with implications for the antiviral efficacy of maribavir. IMPORTANCE: The HCMV UL97 kinase performs important functions in viral replication that are targeted by the antiviral drug maribavir. Here, we describe a naturally occurring short isoform of the kinase that when expressed by itself in a recombinant virus results in altered intracellular localization, impaired growth, and high-level resistance to maribavir compared to those of the predominant full-length counterpart. This is another factor to consider in explaining why maribavir appears to have variable antiviral activity in cell culture and in vivo.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24522923      PMCID: PMC3993794          DOI: 10.1128/JVI.00192-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  59 in total

1.  Recombinant green fluorescent protein-expressing human cytomegalovirus as a tool for screening antiviral agents.

Authors:  M Marschall; M Freitag; S Weiler; G Sorg; T Stamminger
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

2.  Two isoforms of the protein kinase pUL97 of human cytomegalovirus are differentially regulated in their nuclear translocation.

Authors:  Rike Webel; Jens Milbradt; Sabrina Auerochs; Vera Schregel; Christian Held; Katharina Nöbauer; Ebrahim Razzazi-Fazeli; Christophe Jardin; Thomas Wittenberg; Heinrich Sticht; Manfred Marschall
Journal:  J Gen Virol       Date:  2010-11-17       Impact factor: 3.891

3.  Diverse cytomegalovirus UL27 mutations adapt to loss of viral UL97 kinase activity under maribavir.

Authors:  Sunwen Chou
Journal:  Antimicrob Agents Chemother       Date:  2008-11-03       Impact factor: 5.191

4.  Inhibitors of human cytomegalovirus replication drastically reduce the activity of the viral protein kinase pUL97.

Authors:  Manfred Marschall; Matthias Stein-Gerlach; Martina Freitag; Regina Kupfer; Miriam van den Bogaard; Thomas Stamminger
Journal:  J Gen Virol       Date:  2001-06       Impact factor: 3.891

5.  Nuclear import of isoforms of the cytomegalovirus kinase pUL97 is mediated by differential activity of NLS1 and NLS2 both acting through classical importin-α binding.

Authors:  Rike Webel; Sara M Ø Solbak; Christian Held; Jens Milbradt; Andrea Groß; Jutta Eichler; Thomas Wittenberg; Christophe Jardin; Heinrich Sticht; Torgils Fossen; Manfred Marschall
Journal:  J Gen Virol       Date:  2012-05-02       Impact factor: 3.891

6.  Novel chemical class of pUL97 protein kinase-specific inhibitors with strong anticytomegaloviral activity.

Authors:  Thomas Herget; Martina Freitag; Monika Morbitzer; Regina Kupfer; Thomas Stamminger; Manfred Marschall
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

7.  Functional regions of the human cytomegalovirus protein pUL97 involved in nuclear localization and phosphorylation of ganciclovir and pUL97 itself.

Authors:  D Michel; P Schaarschmidt; K Wunderlich; M Heuschmid; L Simoncini; D Mühlberger; A Zimmermann; I Pavić; T Mertens
Journal:  J Gen Virol       Date:  1998-09       Impact factor: 3.891

8.  Cytomegalovirus UL97 kinase mutations that confer maribavir resistance.

Authors:  Sunwen Chou; Laura C Van Wechel; Gail I Marousek
Journal:  J Infect Dis       Date:  2007-05-17       Impact factor: 5.226

9.  The human cytomegalovirus UL97 protein kinase, an antiviral drug target, is required at the stage of nuclear egress.

Authors:  Paula M Krosky; Moon-Chang Baek; Donald M Coen
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

10.  Phosphorylation of retinoblastoma protein by viral protein with cyclin-dependent kinase function.

Authors:  Adam J Hume; Jonathan S Finkel; Jeremy P Kamil; Donald M Coen; Michael R Culbertson; Robert F Kalejta
Journal:  Science       Date:  2008-05-09       Impact factor: 47.728

View more
  15 in total

1.  Complex expression of the UL136 gene of human cytomegalovirus results in multiple protein isoforms with unique roles in replication.

Authors:  Katie Caviness; Louis Cicchini; Michael Rak; Mahadevaiah Umashankar; Felicia Goodrum
Journal:  J Virol       Date:  2014-10-08       Impact factor: 5.103

2.  The proteome of human cytomegalovirus virions and dense bodies is conserved across different strains.

Authors:  Nicole Büscher; Christina Paulus; Michael Nevels; Stefan Tenzer; Bodo Plachter
Journal:  Med Microbiol Immunol       Date:  2015-03-03       Impact factor: 3.402

3.  Cyclins B1, T1, and H differ in their molecular mode of interaction with cytomegalovirus protein kinase pUL97.

Authors:  Mirjam Steingruber; Lena Keller; Eileen Socher; Sabrina Ferre; Anne-Marie Hesse; Yohann Couté; Friedrich Hahn; Nicole Büscher; Bodo Plachter; Heinrich Sticht; Manfred Marschall
Journal:  J Biol Chem       Date:  2019-02-19       Impact factor: 5.157

4.  Antiviral activity of maribavir in combination with other drugs active against human cytomegalovirus.

Authors:  Sunwen Chou; Ronald J Ercolani; Katayoun Derakhchan
Journal:  Antiviral Res       Date:  2018-07-21       Impact factor: 5.970

5.  Long and Short Isoforms of the Human Cytomegalovirus UL138 Protein Silence IE Transcription and Promote Latency.

Authors:  Song Hee Lee; Katie Caviness; Emily R Albright; Jeong-Hee Lee; Christopher B Gelbmann; Mike Rak; Felicia Goodrum; Robert F Kalejta
Journal:  J Virol       Date:  2016-09-29       Impact factor: 5.103

6.  The Interaction between Cyclin B1 and Cytomegalovirus Protein Kinase pUL97 is Determined by an Active Kinase Domain.

Authors:  Mirjam Steingruber; Eileen Socher; Corina Hutterer; Rike Webel; Tim Bergbrede; Tihana Lenac; Heinrich Sticht; Manfred Marschall
Journal:  Viruses       Date:  2015-08-11       Impact factor: 5.048

7.  The cyclin-dependent kinase ortholog pUL97 of human cytomegalovirus interacts with cyclins.

Authors:  Laura Graf; Rike Webel; Sabrina Wagner; Stuart T Hamilton; William D Rawlinson; Heinrich Sticht; Manfred Marschall
Journal:  Viruses       Date:  2013-12-18       Impact factor: 5.048

8.  The Prolyl Isomerase Pin1 Promotes the Herpesvirus-Induced Phosphorylation-Dependent Disassembly of the Nuclear Lamina Required for Nucleocytoplasmic Egress.

Authors:  Jens Milbradt; Corina Hutterer; Hanife Bahsi; Sabrina Wagner; Eric Sonntag; Anselm H C Horn; Benedikt B Kaufer; Yasuko Mori; Heinrich Sticht; Torgils Fossen; Manfred Marschall
Journal:  PLoS Pathog       Date:  2016-08-24       Impact factor: 6.823

9.  Complex Interplay of the UL136 Isoforms Balances Cytomegalovirus Replication and Latency.

Authors:  Katie Caviness; Farah Bughio; Lindsey B Crawford; Daniel N Streblow; Jay A Nelson; Patrizia Caposio; Felicia Goodrum
Journal:  mBio       Date:  2016-03-01       Impact factor: 7.867

10.  Complete Genome Sequence of a Human Cytomegalovirus Strain AD169 Bacterial Artificial Chromosome Clone.

Authors:  Eleonore Ostermann; Michael Spohn; Daniela Indenbirken; Wolfram Brune
Journal:  Genome Announc       Date:  2016-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.